화학공학소재연구정보센터
Biochemical and Biophysical Research Communications, Vol.269, No.3, 671-675, 2000
Recognition of human activated CD44 by tumor vasculature-targeted antibody
TES-23 monoclonal antibody (MAb), which targets rat CD44H on tumor vascular endothelial cells (TEC), dominantly reacted to human activated CD44 rather than human inactive CD44. TES-23 MAb reacted to HT-1080 fibrosarcoma cells almost comparably to antihuman CD44 MAb and moderately to HUVEC; however, it hardly reacted to PBMC, The binding of soluble hyaluronate to HT-1080 cells and HUVEC was clearly noted, but not to PBMC, In addition, stimulation with phorbol 12-myristate 13-acetate induced soluble hyaluronate binding of MOLT-4 human T lymphoma cells and relatively increased the reactivity of TES-23 MAb. Our results suggest that TES-23 MAb can potentially recognize human activated CD44 and hence might be potentially useful for the treatment of human solid tumors containing TEC that express activated CD44.